Mukka Proteins Limited

Mukka Proteins Receives MarinTrust Improver Programme Confirmation

Mukka Proteins Limited received confirmation from Global Trust Certification (NSF) for compliance with the MarinTrust Improver Programme. This three-year certification highlights the company's commitment to responsible sourcing and supply chain sustainability in marine ingredients.

Mukka Proteins to Participate in Investor Group Meetings on Feb 28, 2026

Mukka Proteins Limited will participate in investor group meetings, including a virtual one-on-one with Bandhan MF on February 28, 2026. No unpublished price-sensitive information will be shared. An updated investor presentation is available online.

Mukka Proteins Completes Acquisition, Ento Proteins Becomes Wholly Owned Subsidiary

Mukka Proteins acquired 1,000 equity shares of Ento Proteins Private Limited for ₹32.30 lakh, making it a wholly-owned subsidiary. EPPL reported FY25 turnover of ₹7.46 crore and PAT of ₹49.47 lakh. This acquisition supports Mukka's alternate proteins business expansion.

Mukka Proteins to acquire remaining 25.99% stake in Ento Proteins for ₹32.3 Lakhs

Mukka Proteins Limited will acquire the remaining 25.99% equity in Ento Proteins Private Limited for ₹32.3 Lakhs. This move will increase Mukka Proteins' stake to 100%. The transaction is set for completion following the execution of the Share Purchase Agreement on February 21, 2026.

Mukka Proteins Announces Unaudited Financial Results for Q3FY26

Mukka Proteins Limited announced unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The Board approved these results on February 12, 2026. The results were published in Business Standard and Vijaya Karnataka on February 14, 2026.

Mukka Proteins Presents Q3 & 9M FY26 Investor Presentation, Highlights Growth Strategy

Mukka Proteins released its Q3 & 9M FY26 Investor Presentation. The company, a key player in fish protein, is expanding into insect protein and waste management. It secured a ₹474.89 crore order for leachate treatment and aims for over ₹2,500 crore revenue by FY30. Mukka Proteins is also increasing its stake in EPPL and HMPPL to achieve full ownership.

Mukka Proteins Q3 FY26 Revenue Surges 115.57% YoY to ₹653.50 Cr; Secures ₹474.89 Cr Order

Mukka Proteins reported a strong Q3 FY26 with revenue soaring 115.57% YoY to ₹653.50 crore. The company secured a ₹474.89 crore order for leachate treatment and is expanding its carbon credit portfolio. EBITDA for Q3 FY26 was ₹53.21 crore and PAT was ₹27.25 crore.

Mukka Proteins to acquire 2,000 shares of Haris Marine Products for ₹19.64 Lakh, making it wholly owned subsidiary

Mukka Proteins will acquire 2,000 equity shares of Haris Marine Products Private Limited for ₹19.64 Lakh, making it a wholly owned subsidiary. The acquisition is targeted for completion by June 30, 2026, and is a strategic move to expand the company's core business. HMPPL is a manufacturer and exporter of fish meal and fish oil.

Mukka Proteins to acquire 1,000 shares of EPPL for ₹32.30 Lakhs, making it wholly-owned subsidiary

Mukka Proteins will acquire 1,000 shares of its subsidiary EPPL for ₹32.30 Lakhs. This will make EPPL a wholly-owned subsidiary, increasing Mukka's stake from 74.01% to 100%. The deal is part of strategic expansion in Alternate Proteins business and is expected to complete by June 30, 2026.

Mukka Proteins Amends Insider Trading Code of Conduct

Mukka Proteins Limited has amended its Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders. The updated code was approved by the Board of Directors on February 12, 2026, and is available on the company's website.

Mukka Proteins Approves Unaudited Results, Acquires Full Ownership in Subsidiaries

Mukka Proteins approved unaudited financial results for Q3 FY26. The company will acquire full ownership in EPPL for ₹32.30 lakh and HMPPL for ₹19.64 lakh, making them wholly-owned subsidiaries. These acquisitions are strategic moves to expand alternate protein and core businesses, with completion targeted by June 30, 2026.

Mukka Proteins Board Approves Financial Results, Acquires Full Ownership of Subsidiaries

Mukka Proteins approved unaudited financial results for Q3 FY26. The company will acquire full ownership of subsidiaries Ento Proteins Private Limited and Haris Marine Products Private Limited, with completion expected by June 30, 2026. The Board also amended its insider trading code of conduct.

Mukka Proteins Secures Verra Listing for BSF Project, Expands Capacity to 1,000 TPD

Mukka Proteins' BSF-based waste processing project in Bengaluru is now listed on the Verra Registry (Project ID 5893), advancing toward carbon credit issuance. The company has also received approval to expand its capacity to 1,000 TPD, enhancing its sustainability and revenue diversification potential.

Mukka Proteins Executes LLP Agreement for MPL HRC Ecosolutions LLP

Mukka Proteins Limited executed an LLP agreement with Msjathin Infra Private Limited and Mr. Hardik Gowda on January 22, 2026, for the incorporation of MPL HRC Ecosolutions LLP. The LLP will focus on leachate, water, and bio-waste treatment with an initial capital of ₹5 Lakhs.

Mukka Proteins Incorporates MPL HRC Ecosolutions LLP with 76% Holding

Mukka Proteins Limited incorporated MPL HRC Ecosolutions LLP on January 17, 2026. The company holds a 76% stake with a capital contribution of ₹3,80,000. The LLP will focus on treating and disposing of non-hazardous waste, executing a project for its joint venture.

Mukka Proteins Files SEBI Compliance Certificate for Q3 FY26

Mukka Proteins Limited submitted a compliance certificate for the quarter ended December 31, 2025. The RTA confirmed no demat requests were processed as no shares are held in physical form.

Mukka Proteins' Ratings Downgraded by CARE Ratings; Outlook Revised to Negative

CARE Ratings has downgraded Mukka Proteins' long-term/short-term bank facilities from ₹480 crore to CARE BBB; Negative / CARE A3+. The outlook was revised to Negative from Stable due to a significant increase in working capital cycle to 226 days and inventory build-up to 210 days in FY25. Revenue declined 27% in FY25 but grew 28% in H1 FY26.

Mukka Proteins Vietnam Acquisition Delayed to June 30, 2026

Mukka Proteins Limited's acquisition of Mukka Proteins Vietnam Co., Ltd. is delayed. The expected completion date has been revised from December 31, 2025, to June 30, 2026, due to pending regulatory approvals in Vietnam. The acquisition involves an investment not exceeding ₹10 Lakhs for a 70% stake.

Mukka Proteins Completes Acquisition of Ocean Proteins, Making it a Subsidiary

Mukka Proteins Limited acquired 1,04,500 equity shares of Ocean Proteins Private Limited for ₹1.045 crore. This acquisition makes Ocean Proteins a subsidiary, with Mukka Proteins now holding 51% stake. The move is part of Mukka's strategy to expand its Frozen Fish business.

Mukka Proteins Receives Bond Enforcement Order from Customs; Faces ₹7.67 Crore Duty Demand

Mukka Proteins received a Bond Enforcement Order from Customs demanding ₹7.67 Crore plus applicable interest. This relates to duty-free imports under Advance Licences where export obligations were allegedly not met. The company is reviewing the order and considering legal remedies.

Mukka Proteins: Trading Window Closed from Jan 1, 2026, for Q3 FY26 Results

Mukka Proteins Limited will close its trading window from January 1, 2026. The window will reopen 48 hours after the declaration of financial results for the quarter and nine months ending December 31, 2025. The board meeting date for approving these results will be announced later.

Mukka Proteins Completes 68% Acquisition of United Gulf Fishery for ₹79.56 Lakhs

Mukka Proteins Limited has acquired 68% of United Gulf Fishery Products LLC for ₹79.56 Lakhs (OMR 34,000). This strategic move expands Mukka Proteins' business into the Middle East. The acquisition was completed on December 26, 2025, making United Gulf Fishery a subsidiary.

Mukka Proteins' GST Litigation Concluded, Nil Demand Order Received

Mukka Proteins Limited received a final order on 18th December 2025 concluding GST litigation for FY 2021-22. Initially proposed ₹141.06 crore demand was reduced to ₹27.16 lakh, and the final order resulted in a nil demand for tax, interest, penalty, or late fee. The litigation is now fully resolved.

Mukka Proteins to Incorporate LLP for Waste Management Business

Mukka Proteins will incorporate MPL HRC Ecosolutions LLP with a proposed capital of ₹5,00,000. The company will contribute ₹3,80,000 for a 76% stake to focus on non-hazardous waste treatment. The incorporation is expected by March 31, 2026.

Mukka Proteins Enters Share Transfer Agreement to Acquire 68% Stake in United Gulf Fishery Products LLC

Mukka Proteins to acquire 68% stake in United Gulf Fishery Products LLC for OMR 34,000, pending regulatory compliance, as per Share Transfer Agreement dated 10 December 2025.

Mukka Proteins JV wins ₹474.89 crore order for leachate treatment

Mukka Proteins' JV secures ₹474.89 crore order for legacy leachate treatment in Bengaluru, marking a strategic diversification into sustainability-driven solutions and environmental conservation.

Mukka Proteins Limited Announces Change of Corporate Identification Number (CIN)

Mukka Proteins Limited updated its CIN from L10809KA2010PLC055771 to L10207KA2010PLC055771 after altering its Memorandum of Association.

Mukka Proteins JV Receives ₹474.89 Crore Order from BSWML

Mukka Proteins' JV secures ₹474.89 crore order from BSWML for waste treatment. The project is to be completed in four years.

Mukka Proteins Appoints Ernst & Young LLP as Investor Relations Agency

Mukka Proteins Limited has appointed Ernst & Young LLP as their Investor Relations Agency effective from 1st December 2025.

Mukka Proteins Announces Unaudited Financial Results for Quarter and Half Year Ended September 30, 2025

Mukka Proteins announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. The results were approved by the Board of Directors on November 12, 2025.

Mukka Proteins: Subsidiaries Receive Renewed Consent for Operations

Mukka Proteins' subsidiary and group entities receive renewed Consent for Operation from the Karnataka State Pollution Control Board, valid from 12 Nov 2025 to 30 Sep 2032.

Mukka Proteins to acquire 68% stake in United Gulf Fishery Products LLC

Mukka Proteins to acquire 68% stake in United Gulf Fishery Products LLC for ₹1 crore to expand its business in the Middle East, expecting completion by 31 March 2026.

Mukka Proteins Reports Strong Q2 FY26 Results; Acquires 68% Stake in United Gulf Fishery Products LLC

Mukka Proteins reported strong Q2 FY26 results with increased revenue and profit. The company also announced the acquisition of a 68% stake in United Gulf Fishery Products LLC for ₹1 crore to expand in the Middle East.

Mukka Proteins Board Approves Q2 FY26 Results & Strategic Acquisition of United Gulf Fishery Products LLC

Mukka Proteins' board approved robust Q2 FY26 results with significant revenue and profit growth. It also greenlit acquiring 68% of United Gulf Fishery Products LLC for ₹1 crore, expanding its Middle East presence.

Mukka Proteins Receives Show Cause Notice from Customs

Mukka Proteins received a Show Cause Notice from the Office of the Commissioner of Customs, Mangaluru, for the recovery of export incentives amounting to ₹ 30.37 lakh. The company is reviewing the notice and will respond accordingly.

Mukka Proteins Limited Announces Change of Corporate Identification Number (CIN)

Mukka Proteins Limited updated its CIN from L05004KA2010PLC055771 to L10809KA2010PLC055771 following changes to its Memorandum of Association.

GST Demand Reduced to ₹27.16 Lakh from ₹141.06 Crore

Mukka Proteins: AGM Approves Resolutions with Strong Shareholder Support

Mukka Proteins clarifies on ₹141.06 crore GST demand notice, confident of favorable outcome

Mukka Proteins Limited holds 15th Annual General Meeting on 18th September 2025

Mukka Proteins Receives GST Notice Demanding ₹141.06 Crore

Mukka Proteins acquires 51% stake in FABBCO, strengthens BSF technology and bio-protein capabilities

Mukka Proteins Acquires 51% Stake in Mukka Frozen Impex

Mukka Proteins to hold 15th AGM on 18 Sep 2025; reports decline in FY25 consolidated revenue and profit

Mukka Proteins receives ₹7.82 crore GST demand notice for alleged ineligible IPO-related ITC

Mukka Proteins to hold 15th AGM on September 18, 2025, via video conferencing

Mukka Proteins to invest ₹10 Lakh in Mukka Proteins Vietnam, acquiring 70% stake

Mukka Proteins to acquire 51% stake in Mukka Frozen Impex for ₹5 Crore

Mukka Proteins to provide ₹35.37 Crore Corporate Guarantee to Ocean Proteins